Abstract: For measuring the concentration of a substance in body fluid, such as the glucose level in blood or tissue, a strip electrode (18) and a ring electrode (19) are arranged at the specimen. The ring electrode (19) is in direct electrical contact with the specimen while the strip electrode (18) is electrically insulated therefrom. The strip electrode (18) is arranged parallel to an arm or a leg for obtaining a large interaction length. The electrodes (18, 19) form a capacitor in a resonant circuit. A modulated voltage in the MHz range close to or at the resonance frequency is applied to the electrodes and the response of the body fluid is measured. This design allows a measurement of high accuracy.
Type:
Grant
Filed:
March 6, 2001
Date of Patent:
April 6, 2010
Assignee:
Solianis Holding AG
Inventors:
Thomas W. Schrepfer, Andreas Caduff, Etienne Hirt, Heinz Süsstrunk
Abstract: One aspect of the invention provides a device that non-invasively determines the concentration of a substance in a target. The device includes a first electrode, a measuring circuit, and a data processor. In one embodiment of the device, the first electrode can be electrically insulated from the target, e.g., a cover layer of insulating material covers the first electrode.
Type:
Grant
Filed:
September 5, 2003
Date of Patent:
January 1, 2008
Assignee:
Solianis Holding AG
Inventors:
Andreas Caduff, Etienne Hirt, Thomas W. Schrepfer
Abstract: In order to measure the glucose level in the body tissue of a subject, a probe is applied the subject's skin. Electric pulses from a pulse generator are fed to the probe and partially reflected back to a measuring device, where a time resolved measurement is made. The charge obtained from an integration of the measured voltage is transformed to a glucose level using data from a calibration table. This method allows to monitor glucose non-invasively.